Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network

Auteurs

Loredana Amoroso, Victoria Castel, Gianni Bisogno, Michela Casanova, Catalina Marquez-Vega, Julia C. Chisholm, François Doz, Lucas Moreno, Antonio Ruggiero, Nicolas U. Gerber, Franca Fagioli, Pooja Hingorani, Soledad G. Melcón, Ruta Slepetis, Nianhang Chen, Yvan le Bruchec, Mathew Simcock, Gilles Vassal